Main menu

Pages

Heart surgeon 'probably saved' baby boy's life with 'world's first' stem cell surgery

A heart surgeon has given a baby boy a ‘chance at life’ with a ‘world’s first’ surgery using placental stem cells.

Finley Pantry was born with a congenital heart defect which meant the two main arteries supplying blood to his lungs and body were in the wrong position.

At just four days old, he underwent his first open-heart surgery to return the major arteries to their normal position.

Unfortunately, the newborn suffered complications and his heart function rapidly deteriorated, leaving him stuck in intensive care for weeks, dependent on medication and a ventilator to keep his heart going.

Finley Pantry (pictured with his mother, Melissa Hudd) was born with a congenital heart defect which meant the two main arteries supplying blood to his lungs and body were in the wrong positions

At just four days old, he underwent his first open-heart surgery to return the major arteries to their normal position.

At just four days old, he underwent his first open-heart surgery to return the major arteries to their normal position.

Heart defects: the most common type of abnormality that develops before a baby is born

Heart defects are the most common type of abnormality that develops before a baby is born, with around 13 babies diagnosed with congenital heart disease every day in the UK.

Currently, for many of these infants, surgeons can perform open-heart surgery to temporarily fix the problem, but the materials used for patches or replacement heart valves are not completely biological and cannot grow with the infant. .

This means that a child could therefore have to undergo the same thermal operation several times throughout their childhood, which keeps them in the hospital for weeks at a time.

But, thanks to a doctor, he now lives as a happy two-year-old looking forward to Christmas with his family in Corsham, Wiltshire.

Professor Massimo Caputo, from the Bristol Heart Institute, told Finley’s mother he could try using a pioneering stem cell ‘scaffold’ to correct the heart defect.

The procedure involved stem cells from a placenta bank that were injected directly into Finley’s heart in the hope that they would help damaged blood vessels grow.

Remarkably, Finley was then weaned off the medication and vent he was on – and is now a “happy, growing little boy”.

Finley’s mother, Melissa Hudd, said: ‘We almost lost Finley when he was just two months old. The doctors called us into a room and told us they had done everything they could.

It was then that Massimo came to find us and explained that there was one option left: to inject stem cells into the left side of Finley’s heart.

“He warned us that he could not predict what the outcome would be. But we had absolutely nothing to lose. We had to try to give Finley every possible chance to live.

In just two weeks after the stem cell treatment, the family noticed a change in Finley, and he was sent home for the first time aged six months on a machine that still helps him breathe at night .

Unfortunately, the newborn suffered complications and his heart function rapidly deteriorated, leaving him stuck in intensive care for weeks, dependent on medication and a ventilator to keep his heart going.

Unfortunately, the newborn suffered complications and his heart function rapidly deteriorated, leaving him stuck in intensive care for weeks, dependent on medication and a ventilator to keep his heart going.

Professor Massimo Caputo, from the Bristol Heart Institute, told Finley's mother he could try using a pioneering stem cell 'scaffold' to correct the heart defect.

Professor Massimo Caputo, from the Bristol Heart Institute, told Finley’s mother he could try using a pioneering stem cell ‘scaffold’ to correct the heart defect.

“We can’t thank Massimo enough,” Miss Hudd said. “I believe if it weren’t for the stem cell treatment then Finley wouldn’t be here with us today.

Finley is very feisty and very funny – he’s a real warrior from the heart and I tell him that all the time.

“We don’t know what the future holds, but we are very grateful that Finley’s life has changed after stem cell treatment because he now has a chance to live that he might not have. had otherwise.”

Heart defects are the most common type of abnormality that develops before a baby is born, with around 13 babies diagnosed with congenital heart disease every day in the UK.

Finley now lives as a happy two-year-old looking forward to Christmas with his family in Corsham, Wiltshire

Finley now lives as a happy two-year-old looking forward to Christmas with his family in Corsham, Wiltshire

The stem cell injection treatment Finley received inspired Prof Caputo to develop stem cell 'dressings' that can grow with a child's heart as it ages, removing the need for surgeries repetitive and the many days in the hospital to recuperate after each one.

The stem cell injection treatment Finley received inspired Prof Caputo to develop stem cell ‘dressings’ that can grow with a child’s heart as it ages, removing the need for surgeries repetitive and the many days in the hospital to recuperate after each one.

Currently, for many of these infants, surgeons can perform open-heart surgery to temporarily fix the problem, but the materials used for patches or replacement heart valves are not completely biological and cannot grow with the infant. .

This means that a child could therefore have to undergo the same thermal operation several times throughout their childhood, which keeps them in the hospital for weeks at a time.

The stem cell injection treatment Finley received inspired Prof Caputo to develop stem cell ‘dressings’ that can grow with a child’s heart as it ages, removing the need for surgeries repetitive and the many days in the hospital to recuperate after each one.

Professor Caputo has now received £750,000 from the British Heart Foundation to prepare these patches for testing in patients, so clinical trials can begin within the next two years.

Professor Caputo has now received £750,000 from the British Heart Foundation to prepare these patches for testing in patients, so clinical trials can begin within the next two years.

Professor Caputo has now received £750,000 from the British Heart Foundation to prepare these patches for testing in patients, so clinical trials can begin within the next two years.

He said: “For years we have had families come to us asking why their child has had to have heart surgery time and time again.

Although each operation can save lives, the experience can place incredible stress on the child and their parents.

“We believe that our stem cell patches will be the answer to solving these problems.”

If you liked this article:

Scientists are creating ‘mini eyes’ in the lab in a breakthrough that could help thousands of people at risk of losing their sight

Scientists are developing a new technique to rejuvenate skin cells claiming it can delay aging by 30 years.

Breakthrough male infertility as scientists successfully create viable sperm from monkey stem cells

Stem cells help researchers study mammalian development, allowing them to fight disease and create organs for human transplants

Stem cells are the body’s raw materials – a basic cell type that can grow into another, more specialized cell type through a process called differentiation.

Think of stem cells as a ball of fresh clay that can be shaped and transformed into any cell in the body – including bones, muscles, skin and more.

This ability means they have been the subject of much medical research over the past few decades.

They develop in embryos as embryonic stem cells, helping the rapidly growing infant form the millions of different cell types it needs to build before birth.

Embryonic stem cells used in research come from unused embryos, which are the result of an in vitro fertilization procedure and are donated to science.

In adults, they are used as repair cells, replacing those we lose due to damage or aging.

For adults, there are two types: one type arises from fully developed tissues such as the brain, skin, and bone marrow; the other includes pluripotent stem cells.

Pluripotent stem cells have been modified in the laboratory to look more like embryonic stem cells.

.

Comments